panel: safety and efficacy considerations for cell and gene therapies
Published 3 years ago • 59 plays • Length 1:02:29Download video MP4
Download video MP3
Similar videos
-
23:40
expediting the development of cell and gene therapy
-
41:38
panel: durable gmp compliance for cell and gene therapies
-
2:05
the challenges of cmc in cell and gene therapies
-
46:39
what’s next for cell and gene therapies in 2023 and beyond
-
1:11:29
panel: acceptance and uptake of cell and gene therapies: lessons learned and future focus
-
28:17
featured fireside chat: brexit's effect on cell and gene therapy regulation
-
1:05:49
panel: cell and gene therapies for chronic conditions
-
16:25
fda’s efforts to advance the development and approval of cellular and gene therapies
-
49:16
panel: the state of investment in cell and gene therapy
-
25:17
panel: ex vivo gene therapy: using stem cells to treat genetic disorders - florian eichler, harvard
-
59:51
panel: next generation cell and gene therapy in oncology
-
54:19
panel: cell and gene therapy for neurological product indications
-
45:22
panel: the investment outlook for the cell and gene therapy space
-
55:09
panel: myth vs reality - implementing payment arrangements for cell and gene therapies
-
24:29
meeting regulatory requirements for cell and gene therapy manufacturing
-
52:32
panel: when does investing in cell and gene therapy make business sense?
-
53:56
panel: cell and gene therapies for ophthalmologic diseases
-
47:03
current challenges, opportunities and trends in gene editing and gene therapy workshop
-
1:00:31
cell and gene therapies manufacturing: exploring next-generation platform technologies